Paroxetina Bluepharma may be available in the countries listed below.
Paroxetine is reported as an ingredient of Paroxetina Bluepharma in the following countries:
International Drug Name Search
Generic Name: betamethasone dipropionate (Topical application route)
bay-ta-METH-a-sone dye-PROE-pee-oh-nate
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Corticosteroid, Strong
Pharmacologic Class: Betamethasone
Betamethasone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid (cortisone-like medicine or steroid).
This medicine is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of betamethasone topical in children 13 years of age and older. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. Use in children 12 years of age and younger is not recommended.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of betamethasone topical in the elderly.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain betamethasone. It may not be specific to Del-Beta. Please read with care.
It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.
This medicine is for use on the skin only. Do not get it in your eyes. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.
This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.
Do not use the topical gel and lotion on the face, groin, or underarms unless directed to do so by your doctor.
To use:
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.
If your or your child's symptoms do not improve within two weeks, or if they become worse, check with your doctor.
Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.
Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.
Do not use cosmetics or other skin care products on the treated areas.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Del-Beta side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Diazepan Biocrom may be available in the countries listed below.
Diazepam is reported as an ingredient of Diazepan Biocrom in the following countries:
International Drug Name Search
Lacerol Hta may be available in the countries listed below.
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Lacerol Hta in the following countries:
International Drug Name Search
Valproat may be available in the countries listed below.
Valproic Acid semisodium (a derivative of Valproic Acid) is reported as an ingredient of Valproat in the following countries:
International Drug Name Search
Drill pastilles avec et sans sucre may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Drill pastilles avec et sans sucre in the following countries:
Tetracaine hydrochloride (a derivative of Tetracaine) is reported as an ingredient of Drill pastilles avec et sans sucre in the following countries:
International Drug Name Search
Timolol Santen may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Timolol Santen in the following countries:
International Drug Name Search
Dermazyme-Acti-Bac may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorhexidine is reported as an ingredient of Dermazyme-Acti-Bac in the following countries:
Phenoxyethanol is reported as an ingredient of Dermazyme-Acti-Bac in the following countries:
International Drug Name Search
Dulcoenema may be available in the countries listed below.
Glycerol is reported as an ingredient of Dulcoenema in the following countries:
International Drug Name Search
Simvastatine Teva may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatine Teva in the following countries:
International Drug Name Search
In the US, Perflutren (perflutren systemic) is a member of the drug class ultrasound contrast media.
US matches:
Rec.INN
V08D,V09G
0000076-19-7
C3-F8
188
Diagnostic agent
Octafluoropropane (WHO)
Propane, octafluoro- (USAN)
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Platinox may be available in the countries listed below.
Cisplatin is reported as an ingredient of Platinox in the following countries:
International Drug Name Search
Biorgan may be available in the countries listed below.
Trimebutine is reported as an ingredient of Biorgan in the following countries:
International Drug Name Search
Diclofénac CristerS may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofénac CristerS in the following countries:
International Drug Name Search
Dolal may be available in the countries listed below.
Paracetamol is reported as an ingredient of Dolal in the following countries:
International Drug Name Search
Codeinefosfaat A may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codeinefosfaat A in the following countries:
International Drug Name Search
Renopent may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Renopent in the following countries:
International Drug Name Search
Difemic may be available in the countries listed below.
Dicycloverine hydrochloride (a derivative of Dicycloverine) is reported as an ingredient of Difemic in the following countries:
Mefenamic Acid is reported as an ingredient of Difemic in the following countries:
International Drug Name Search
Dicef may be available in the countries listed below.
Cefradine is reported as an ingredient of Dicef in the following countries:
International Drug Name Search
Dizole may be available in the countries listed below.
Fluconazole is reported as an ingredient of Dizole in the following countries:
International Drug Name Search
Phloroglucinol RPG may be available in the countries listed below.
Phloroglucinol is reported as an ingredient of Phloroglucinol RPG in the following countries:
International Drug Name Search
Dimenidrinato Afom may be available in the countries listed below.
Dimenhydrinate is reported as an ingredient of Dimenidrinato Afom in the following countries:
International Drug Name Search
Pravastatina Farmoz may be available in the countries listed below.
Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatina Farmoz in the following countries:
International Drug Name Search
Dexamethasone-Organon may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Dexamethasone-Organon in the following countries:
International Drug Name Search
Volna-K may be available in the countries listed below.
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Volna-K in the following countries:
International Drug Name Search
Neupax may be available in the countries listed below.
Alprazolam is reported as an ingredient of Neupax in the following countries:
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Neupax in the following countries:
International Drug Name Search
Rivaprozole may be available in the countries listed below.
Omeprazole is reported as an ingredient of Rivaprozole in the following countries:
International Drug Name Search
Domilux may be available in the countries listed below.
Domperidone is reported as an ingredient of Domilux in the following countries:
International Drug Name Search
Amoxicillina + Acido clavulanico Mylan may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina + Acido clavulanico Mylan in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicillina + Acido clavulanico Mylan in the following countries:
International Drug Name Search
Pantin may be available in the countries listed below.
Pantoprazole is reported as an ingredient of Pantin in the following countries:
International Drug Name Search
Acetazolamida may be available in the countries listed below.
Acetazolamide is reported as an ingredient of Acetazolamida in the following countries:
International Drug Name Search
Delphicort may be available in the countries listed below.
Triamcinolone is reported as an ingredient of Delphicort in the following countries:
Triamcinolone 16α,21-diacetate (a derivative of Triamcinolone) is reported as an ingredient of Delphicort in the following countries:
International Drug Name Search
Diazepan Medipharma may be available in the countries listed below.
Diazepam is reported as an ingredient of Diazepan Medipharma in the following countries:
International Drug Name Search
Diazepam Teva may be available in the countries listed below.
Diazepam is reported as an ingredient of Diazepam Teva in the following countries:
International Drug Name Search
Azathioprine Ratiopharm may be available in the countries listed below.
Azathioprine is reported as an ingredient of Azathioprine Ratiopharm in the following countries:
International Drug Name Search
Roxide may be available in the countries listed below.
Roxithromycin is reported as an ingredient of Roxide in the following countries:
International Drug Name Search
Reumacap may be available in the countries listed below.
Indometacin is reported as an ingredient of Reumacap in the following countries:
International Drug Name Search
Teovent may be available in the countries listed below.
Choline Theophyllinate is reported as an ingredient of Teovent in the following countries:
International Drug Name Search
Ambroxol Normon may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambroxol Normon in the following countries:
International Drug Name Search
Finasterax may be available in the countries listed below.
Finasteride is reported as an ingredient of Finasterax in the following countries:
International Drug Name Search
Nudon may be available in the countries listed below.
Domperidone is reported as an ingredient of Nudon in the following countries:
International Drug Name Search
Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Vibramycin Hyclate in the following countries:
International Drug Name Search
JAN
0009007-43-6
Protein
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
Yazon may be available in the countries listed below.
Cefoperazone is reported as an ingredient of Yazon in the following countries:
International Drug Name Search
Sakecitonin may be available in the countries listed below.
Calcitonin is reported as an ingredient of Sakecitonin in the following countries:
International Drug Name Search
Ovurelin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Gonadorelin acetate (a derivative of Gonadorelin) is reported as an ingredient of Ovurelin in the following countries:
International Drug Name Search
Relif may be available in the countries listed below.
Nabumetone is reported as an ingredient of Relif in the following countries:
International Drug Name Search
Futasone may be available in the countries listed below.
Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Futasone in the following countries:
Fusidic Acid is reported as an ingredient of Futasone in the following countries:
International Drug Name Search
Verapamil HCl PCH may be available in the countries listed below.
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamil HCl PCH in the following countries:
International Drug Name Search
Ramipril-1A Pharma plus may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Ramipril-1A Pharma plus in the following countries:
Ramipril is reported as an ingredient of Ramipril-1A Pharma plus in the following countries:
International Drug Name Search
Loxan may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Loxan in the following countries:
International Drug Name Search
Lioresyl may be available in the countries listed below.
Baclofen is reported as an ingredient of Lioresyl in the following countries:
International Drug Name Search
Folsäure Lomapharm may be available in the countries listed below.
Folic Acid is reported as an ingredient of Folsäure Lomapharm in the following countries:
International Drug Name Search
Dominium may be available in the countries listed below.
Fluoxetine is reported as an ingredient of Dominium in the following countries:
Sertraline is reported as an ingredient of Dominium in the following countries:
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Dominium in the following countries:
International Drug Name Search
Terbinal may be available in the countries listed below.
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinal in the following countries:
International Drug Name Search
In the US, Sarafem (fluoxetine systemic) is a member of the drug class selective serotonin reuptake inhibitors and is used to treat Premenstrual Dysphoric Disorder.
US matches:
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Sarafem in the following countries:
International Drug Name Search
Meixil may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Meixil in the following countries:
International Drug Name Search
Scorpan may be available in the countries listed below.
Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Scorpan in the following countries:
International Drug Name Search
Voltarol may be available in the countries listed below.
UK matches:
Diclofenac is reported as an ingredient of Voltarol in the following countries:
Diclofenac hydroxyethylpyrrolidine (a derivative of Diclofenac) is reported as an ingredient of Voltarol in the following countries:
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Voltarol in the following countries:
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltarol in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Dexamphetamine Tablets may be available in the countries listed below.
Dexamfetamine sulfate (a derivative of Dexamfetamine) is reported as an ingredient of Dexamphetamine Tablets in the following countries:
International Drug Name Search
Allopurinol Gen Med may be available in the countries listed below.
Allopurinol is reported as an ingredient of Allopurinol Gen Med in the following countries:
International Drug Name Search
Duspatal Retard may be available in the countries listed below.
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Duspatal Retard in the following countries:
International Drug Name Search
Natriumvalproaat ratiopharm may be available in the countries listed below.
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Natriumvalproaat ratiopharm in the following countries:
International Drug Name Search
Mastidina Pomada may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Phenol is reported as an ingredient of Mastidina Pomada in the following countries:
International Drug Name Search
Diazépam Renaudin may be available in the countries listed below.
Diazepam is reported as an ingredient of Diazépam Renaudin in the following countries:
International Drug Name Search
Mircette is a brand name of desogestrel/ethinyl estradiol, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Mircette:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mircette. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Mircette.
Rec.INN
D07AB04
0033124-50-4
C22-H27-F-O5
390
Adrenal cortex hormone, glucocorticoid
Pregna-1,4-dien-21-oic acid, 6-fluoro-11-hydroxy-16-methyl-3,20-dioxo-, (6α,11ß,16α)-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Class Name: beta-adrenergic blocker (Ophthalmic route)
In the U.S.
In Canada
Available Dosage Forms:
Beta-adrenergic blocking agents for the eye are used to treat certain types of glaucoma. They appear to work by reducing the production of fluid in the eye. This lowers the pressure in the eye.
These medicines are available only with your doctor's prescription.
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Infants may be especially sensitive to the effects of ophthalmic beta-adrenergic blocking agents. This may increase the chance of side effects during treatment.
Elderly people are especially sensitive to the effects of ophthalmic beta-adrenergic blocking agents. If too much medicine is absorbed into the body, the chance of side effects during treatment may be increased.
Ophthalmic beta-adrenergic blocking agents may be absorbed into the body. These medicines have not been studied in pregnant women. Studies in animals have not shown that betaxolol, levobunolol, metipranolol, or timolol causes birth defects. However, high doses of levobetaxolol given by mouth to pregnant rabbits have been shown to cause birth defects in rabbit babies, and very large doses of carteolol given by mouth to pregnant rats have been shown to cause wavy ribs in rat babies. In addition, some studies in animals have shown that beta-adrenergic blocking agents increase the chance of death in the animal fetus. Before using ophthalmic beta-adrenergic blocking agents, make sure your doctor knows if you are pregnant or if you may become pregnant.
Betaxolol and timolol, and maybe other beta-adrenergic blocking agents, when taken by mouth, may pass into the breast milk. Since ophthalmic beta-adrenergic blocking agents may be absorbed into the body, they, too, may pass into the breast milk. However, it is not known whether ophthalmic beta-adrenergic blocking agents pass into the breast milk, and these medicines have not been reported to cause problems in nursing babies.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these medicines, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using medicines in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of medicines in this class. Make sure you tell your doctor if you have any other medical problems, especially:
To use:
Use this medicine only as directed. Do not use more of it and do not use it more often than your doctor ordered. To do so may increase the chance of too much medicine being absorbed into the body and the chance of side effects.
The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Call your doctor or pharmacist for instructions.
If you miss a dose of this medicine and your dosing schedule is:
If you have any questions about this, check with your doctor.
Keep out of the reach of children.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Do not keep outdated medicine or medicine no longer needed.
Store levobetaxolol in an upright position.
Your doctor should check your eye pressure at regular visits to make certain that your glaucoma is being controlled.
Contact your physician immediately if you are having eye surgery, you experience trauma to your eye, or you develop an eye infection to determine if you should continue to use your present container of eye drops.
For a short time after you use this medicine, your vision may be blurred. Make sure your vision is clear before you drive, use machines, or do anything else that could be dangerous if you are not able to see well.
Before you have any kind of surgery, dental treatment, or emergency treatment, tell the medical doctor or dentist in charge that you are using this medicine. Using an ophthalmic beta-adrenergic blocking agent during this time may cause an increased risk of side effects.
For diabetic patients:
Some ophthalmic beta-adrenergic blocking agents (betaxolol, carteolol, and metipranolol) may cause your eyes to become more sensitive to light than they are normally. Wearing sunglasses and avoiding too much exposure to bright light may help lessen the discomfort.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
The side effect of blurred vision is associated primarily with levobetaxolol and the timolol gel-forming solution and usually lasts from thirty seconds to five minutes.
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Healthcare (Micromedex) products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Healthcare does not assume any responsibility or risk for your use of the Thomson Healthcare products.
Calcitonin-Rotexmedica may be available in the countries listed below.
Calcitonin is reported as an ingredient of Calcitonin-Rotexmedica in the following countries:
International Drug Name Search
Zepilen may be available in the countries listed below.
Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Zepilen in the following countries:
International Drug Name Search
Ketomicol may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Ketomicol in the following countries:
International Drug Name Search
Naproxen Copyfarm may be available in the countries listed below.
Naproxen is reported as an ingredient of Naproxen Copyfarm in the following countries:
International Drug Name Search
Dompenyl may be available in the countries listed below.
Domperidone is reported as an ingredient of Dompenyl in the following countries:
International Drug Name Search
Phenyl Aminosalicylate may be available in the countries listed below.
Phenyl Aminosalicylate (BAN, USAN) is also known as Fenamisal (Rec.INN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Didrokit may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Didrokit in the following countries:
Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Didrokit in the following countries:
International Drug Name Search
Overdose-like side effects (eg, severe drowsiness, coma, confusion, mental changes), uncontrolled muscle movements, stiff or shaky muscles, trouble talking, joint pain, decreased coordination, aggression, dizziness, weakness, high blood pressure, and seizures have occurred in some patients after injection with Olanzapine Extended-Release. In most cases, the reaction occurred within 1 to 3 hours after the injection. You will need to be monitored by a health care professional for at least 3 hours after you receive Olanzapine Extended-Release. However, these symptoms may develop more than 3 hours after you receive a dose of Olanzapine Extended-Release. Tell your doctor right away if you develop any of these symptoms. Discuss any questions or concerns with your doctor.
Olanzapine Extended-Release is an antipsychotic. It may increase the risk of death when used to treat mental problems caused by dementia in elderly patients. Most of the deaths were linked to heart problems or infection. Olanzapine Extended-Release is not approved to treat mental problems caused by dementia.
Treating schizophrenia. It may also be used for other conditions as determined by your doctor.
Olanzapine Extended-Release is an atypical antipsychotic. Exactly how it works is not known. It is thought to affect certain substances in the brain.
Contact your doctor or health care provider right away if any of these apply to you.
Treatments for depression are getting better everyday and there are things you can start doing right away.
Some medical conditions may interact with Olanzapine Extended-Release. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Olanzapine Extended-Release. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Olanzapine Extended-Release may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Olanzapine Extended-Release as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Olanzapine Extended-Release.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Back pain; constipation; cough; diarrhea; dizziness; drowsiness; dry mouth; headache; increased appetite; lightheadedness; nausea; pain, redness, or swelling at the injection site; sore throat; stuffy nose; tiredness; vomiting; weight gain.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); abnormal thoughts; chest pain; confusion; decreased urination; disorientation; fainting; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; increased saliva production or drooling; increased sweating; memory loss; menstrual changes; muscle pain, weakness, or stiffness; new or worsening mental or mood changes (eg, agitation, depression, hallucinations); one-sided weakness; seizures; severe or prolonged drowsiness, dizziness, or headache; shortness of breath; suicidal thoughts or actions; swelling of the hands, legs, or feet; symptoms of high blood sugar (eg, increased thirst, hunger, or urination; unusual weakness); symptoms of high prolactin levels (eg, enlarged breast size, decreased sexual ability, missed menstrual period, nipple discharge); tremor; trouble concentrating, speaking, or swallowing; trouble sitting still; trouble walking or standing; uncontrolled muscle movements (eg, arm or leg movements, twitching of the face or tongue, jerking or twisting); unusual bruising; vision changes; yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Olanzapine Extended-Release side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include abnormal thinking; aggression; agitation; chest pain; coma; confusion; difficult or slurred speech; fainting; fast or irregular heartbeat; fever; mental or mood changes; seizure; severe drowsiness, dizziness, or weakness; severe or persistent headache; slow or shallow breathing; stiff muscles; sweating; trouble walking; uncontrolled muscle movements.
Olanzapine Extended-Release is usually handled and stored by a health care provider. If you are using Olanzapine Extended-Release at home, store Olanzapine Extended-Release as directed by your pharmacist or health care provider. Keep Olanzapine Extended-Release out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Olanzapine Extended-Release. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
